Lisdexamfetamine Dimesylate Tablet, Chewable shortage
Current 18 presentations · 3 manufacturers · first FDA posting Jul 14, 2023 · last update Oct 15, 2026
Manufacturers: Novadoz Pharmaceuticals LLC, Sun Pharmaceutical Industries, Inc., Takeda Pharmaceuticals USA Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted Jul 14, 2023 Updated Sep 16, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted Jul 14, 2023 Updated Sep 16, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted Jul 14, 2023 Updated Sep 16, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted Jul 14, 2023 Updated Sep 16, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted Jul 14, 2023 Updated Sep 16, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted Jul 14, 2023 Updated Sep 16, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Sep 18, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Sep 18, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Sep 18, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Sep 18, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Sep 18, 2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Sep 18, 2026 | |
| Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Oct 15, 2026 | |
| Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Oct 15, 2026 | |
| Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Oct 15, 2026 | |
| Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Oct 15, 2026 | |
| Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Oct 15, 2026 | |
| Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted Jul 14, 2023 Updated Oct 15, 2026 |